[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100597165":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":10,"centralContacts":19,"locations":24,"responsibleParty":42,"collaborators":10,"id":46,"slug":47,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":52,"eligibilityCriteria":53,"healthyVolunteers":48,"sex":54,"minAge":55,"maxAge":56,"enrollmentInfo":57,"targetDuration":10,"studyType":60,"phases":10,"briefSummary":61,"conditions":62,"keywords":67,"overallStatus":27,"whyStopped":10,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"University of Rochester","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"Indocyanine Green (ICG) and KARL STORZ ICG Imaging System",null,[12],"Diagnostic Test: ICG (Indocyanine Green)",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"DIAGNOSTIC_TEST","ICG (Indocyanine Green)","Lymphatic mapping",[9],[20],{"name":21,"role":22,"phone":10,"phoneExt":10,"email":23},"Abdelhafeez Abdelhafeez, MD","CONTACT","Abdelhafeez_Abdelhafeez@URMC.Rochester.edu",[25],{"facility":26,"status":27,"city":28,"state":29,"zip":30,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"University of Rochester Medical Center","RECRUITING","Rochester","New York","14642","United States","US",{"type":34,"coordinates":35},"Point",[36,37],-77.61556,43.15478,{"lat":37,"lon":36},[40],{"name":41,"role":22,"phone":10,"phoneExt":10,"email":23},"Abdelhafeez Abdelhafeez",{"type":43,"investigatorFullName":44,"investigatorTitle":45,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Hafeez Abdel","Associate Professor - Department of Surgery, Pediatric Surgery (SMD)","100597165","tumor-lymph-node-mapping-100597165",false,"NCT07054944","Tumor-Lymph Node Mapping","FEASIBILITY AND SAFETY OF INDOCYANINE GREEN (ICG) GUIDED SENTINEL LYMPH NODE MAPPING FOR PEDIATRIC SOLID TUMORS - T-LyM (Tumor-Lymph Node Mapping)","T-LyM","Inclusion Criteria:\n\n* Any pediatric patient (under the age of 18 years) being treated at the University of Rochester Medical Center, Department of Surgery.\n* Diagnosed with pediatric solid tumor\n* Scheduled to undergo lymph node sampling as part of their clinical management.\n\nExclusion Criteria:\n\n* Subjects with a history of iodide allergies.\n* Inability or unwillingness of research participant or parent\u002Flegal guardian to give written informed consent.\n* Currently pregnant.\n* Infants under 650 grams.\n* Patients with extensive prior surgery at the primary site or nodal basin expected to affect the lymphatic drainage.","ALL","1 Month","17 Years",{"count":58,"type":59},10,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to assess the feasibility and safety of ICG-guided intraoperative lymphography for detecting sentinel lymph nodes (SLN) in pediatric patients with solid tumors who require retroperitoneal lymph node dissection\u002Fsampling.\n\nThis trial is a single-site cross-sectional study. The injection of ICG directly into lymphatics draining the primary tumor will take place at the time of operation after the patient is under anesthesia.",[63,64,65,66],"Pediatric Solid Tumors","Rhabdomyosarcoma","Sarcoma","Germ Cell Tumor",[68],"PEDIATRIC CANCER","2026-04-20",{"date":71,"type":72},"2026-04-23","ACTUAL",{"date":74,"type":59},"2026-04-13",{"date":76,"type":59},"2028-07-30",{"name":5,"class":6},1]